Literature DB >> 20138564

Surgical outcomes and prognostic factors of oral cancer associated with betel quid chewing and tobacco smoking in Taiwan.

Shyun-Yeu Liu1, Chin-Li Lu, Chang-Ta Chiou, Ching-Yu Yen, Gwo-An Liaw, Yi-Chun Chen, Yu-Chi Liu, Wei-Fan Chiang.   

Abstract

Oral squamous cell carcinoma (OSCC) is one of the most common cancers in geographic regions where betel quid (BQ) chewing is prevalent; OSCC is an extremely malignant neoplasm whose prognostic factors are multiple and complex. The purpose of this study was to assess clinicopathological prognostic factors and treatment outcomes in 698 consecutive OSCC patients who had undergone surgery as the primary treatment in an area with a high prevalence of both betel quid chewing and tobacco smoking. The prognostic factors were predicted using Cox's proportional-hazards regression model, and the survival rate was calculated using Kaplan-Meier analysis. The median followup for all patients was 44 months. The 5-year cumulative overall, disease-specific, and locoregional control survival rates were 61%, 62%, and 46%, respectively. Multivariate analysis showed that the lower level of nodal metastasis, advanced stage, tumor thickness >7 mm, and treatment failures were independent risk factors of overall survival. Furthermore, history of alcohol drinking, lower level of nodal metastasis, advanced stage, poor cell differentiation, and treatment failures were independent predictors of poor disease-specific survival. However, we did not find any significant factor that affected locoregional recurrence. Due to the high frequencies of locoregional recurrence and second primary cancer, our findings emphasize that aggressive surgical excision, adjuvant treatments according to clinicopathological prognostic factors and close surveillance are important to the survival of OSCC patients in an area with a high prevalence of betel quid chewing and tobacco smoking. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20138564     DOI: 10.1016/j.oraloncology.2010.01.008

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  11 in total

1.  A novel environmental exposure index and its interaction with familial susceptibility on oral cancer in non-smokers and non-drinkers: a case-control study.

Authors:  Lingjun Yan; Fa Chen; Baochang He; Fengqiong Liu; Fangping Liu; Jiangfeng Huang; Junfeng Wu; Lisong Lin; Yu Qiu; Lin Cai
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-19       Impact factor: 2.503

2.  The cost-effectiveness of community-based screening for oral cancer in high-risk males in the United States: a Markov decision analysis approach.

Authors:  Raj C Dedhia; Kenneth J Smith; Jonas T Johnson; Mark Roberts
Journal:  Laryngoscope       Date:  2011-03-07       Impact factor: 3.325

3.  Expression analysis of SPARC/osteonectin in oral squamous cell carcinoma patients: from saliva to surgical specimen.

Authors:  Gabriella Aquino; Rocco Sabatino; Monica Cantile; Corrado Aversa; Franco Ionna; Gerardo Botti; Elvira La Mantia; Francesca Collina; Gabriella Malzone; Giuseppe Pannone; Nunzia Simona Losito; Renato Franco; Francesco Longo
Journal:  Biomed Res Int       Date:  2013-12-16       Impact factor: 3.411

4.  Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.

Authors:  Gu-Jiun Lin; Yen-Sung Huang; Chih-Kung Lin; Shing-Hwa Huang; Hsiu-Ming Shih; Huey-Kang Sytwu; Yuan-Wu Chen
Journal:  Clin Oral Investig       Date:  2015-07-24       Impact factor: 3.573

5.  Subsite-specific association of DEAD box RNA helicase DDX60 with the development and prognosis of oral squamous cell carcinoma.

Authors:  Ting-Ying Fu; Chao-Nan Wu; Huei-Cin Sie; Jiin-Tsuey Cheng; Yaoh-Shiang Lin; Huei-Han Liou; Yu-Kai Tseng; Chih-Wen Shu; Kuo-Wang Tsai; Leing-Ming Yen; Hui-Wen Tseng; Ching-Jiunn Tseng; Luo-Ping Ger; Pei-Feng Liu
Journal:  Oncotarget       Date:  2016-12-20

6.  Molecular Biomarkers Related to Oral Carcinoma: Clinical Trial Outcome Evaluation in a Literature Review.

Authors:  Gabriele Cervino; Luca Fiorillo; Alan Scott Herford; Umberto Romeo; Alberto Bianchi; Salvatore Crimi; Cesare D'Amico; Rosa De Stefano; Giuseppe Troiano; Rossella Santoro; Luigi Laino; Gregorio Laino; Marco Cicciù
Journal:  Dis Markers       Date:  2019-03-25       Impact factor: 3.434

Review 7.  Emerging Functions of Human IFIT Proteins in Cancer.

Authors:  Vijaya Kumar Pidugu; Hima Bindu Pidugu; Meei-Maan Wu; Chung-Ji Liu; Te-Chang Lee
Journal:  Front Mol Biosci       Date:  2019-12-19

8.  Prognostic factors analysis for oral cavity cancer survival in the Netherlands and Taiwan using a privacy-preserving federated infrastructure.

Authors:  Gijs Geleijnse; RuRu Chun-Ju Chiang; Melle Sieswerda; Melinda Schuurman; K C Lee; Johan van Soest; Andre Dekker; Wen-Chung Lee; Xander A A M Verbeek
Journal:  Sci Rep       Date:  2020-11-25       Impact factor: 4.379

9.  Combined effects of icam-1 single-nucleotide polymorphisms and environmental carcinogens on oral cancer susceptibility and clinicopathologic development.

Authors:  Chiao-Wen Lin; Chun-Yi Chuang; Chih-Hsin Tang; Junn-Liang Chang; Liang-Ming Lee; Wei-Jiunn Lee; Jyh-Ming Chow; Shun-Fa Yang; Ming-Hsien Chien
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

10.  Trends in clinical features and survival of oral cavity cancer: fifty years of experience with 3,362 consecutive cases from a single institution.

Authors:  Shu-Wei Chen; Quan Zhang; Zhu-Ming Guo; Wen-Kuan Chen; Wei-Wei Liu; Yan-Feng Chen; Qiu-Li Li; Xue-Kui Liu; Hao Li; Dian Ou-Yang; Wei-Chao Chen; Xiao-Yan Fu; Xi-Di Wang; An-Kui Yang; Jin-Xin Bei; Ming Song
Journal:  Cancer Manag Res       Date:  2018-10-12       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.